Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience.

Katherine Lee ChuyEvangelos K OikonomouMichael A PostowMargaret K CallahanPaul B ChapmanAlexander N ShoushtariTomas G NeilanMichael G FradleyLakshmi V RamanathanJedd D WolchokRichard M SteingartDipti Gupta

Published in: The oncologist (2019)

This letter to the editor describes myocarditis screening among patients undergoing combination immune checkpoint inhibitor therapy, in light of the consensus document from the Checkpoint Inhibitor Safety Working Group.

Keyphrases

patients undergoing
public health
papillary thyroid
stem cells
cell cycle
oxidative stress
squamous cell
cell therapy
clinical practice
lymph node metastasis
childhood cancer